Author: STITCHES Newsletter

A nomogram for predicting postoperative pancreatic fistula risk after distal pancreatectomy

A new nomogram accurately predicts clinically relevant postoperative pancreatic fistula (cr-popf), helping surgeons identify high-risk patients. 28% of patients developed cr-popf in a study of 300 cases. Key independent risk factors include operation time, preoperative C-reactive protein levels, CT pancreas-to-CT psoas major ratio, and pancreatic thickness. The nomogram shows excellent predictive power with an AUC […]

Robotic Pancreatoduodenectomy Outcomes Improve Significantly

Increasing experience results in better outcomes for robotic pancreatoduodenectomies. Operating time decreased from 420 to 369 minutes across learning phases. Conversion rate dropped from 21.7% to 7.5%. Rate of delayed gastric emptying improved from 32.3% to 15.4%. Surgeons should consider patient selection and institutional experience when planning robotic procedures to enhance recovery and minimize complications. […]

Enhanced Detection with Probe-Based Confocal Laser Endomicroscopy

Probe-based confocal laser endomicroscopy (pCLE) significantly improves real-time diagnosis during endoscopy for various gastrointestinal conditions. In Barrett’s esophagus, pCLE nearly doubles neoplasia detection sensitivity compared to conventional methods. For gastric intestinal metaplasia, sensitivity reached 97% and specificity 94%. Colorectal lesion evaluation shows sensitivity of 81-91% and specificity of 75-91%, reducing unnecessary resections. PCLE can lead […]

Laparoscopic Splenectomy Enhances Recompensation in Cirrhosis

Laparoscopic splenectomy significantly improves liver function in decompensated cirrhosis patients. 73% of patients treated with splenectomy achieved recompensation versus 33% with endoscopic therapy. Recompensation contributed to a 43% reduction in mortality over 3 years, dropping to 16% by 8 years. Younger patients have better outcomes with this approach. Overall, 54% of patients in the study […]

Intraoperative Blood Loss Affects Pancreatic Fistula Rates

Intraoperative blood loss is a key risk factor for postoperative pancreatic fistula (POPF) in pancreatic surgery, impacting patient recovery. Among 13,108 patients, the overall POPF rate was 20%. In patients with POPF, intraoperative blood loss was 112.46 ml higher than those without, highlighting its significance as an independent risk factor. Minimizing blood loss during surgery […]

Hemoglobin-to-albumin ratio predicts complications after gastrectomy

Higher hemoglobin-to-albumin ratios are linked to fewer complications post-radical gastrectomy in gastric cancer patients. A 1-unit increase in the hemoglobin-to-albumin ratio reduces the risk of moderate to severe complications (Clavien-Dindo ≥II) by 62%. This study analyzed data from 352 patients, establishing a clear correlation between nutritional status and surgical outcomes. Monitor hemoglobin-to-albumin ratios to optimize […]

Strategies to Reduce Delayed Gastric Emptying Post-Pancreatic Surgery

Delayed gastric emptying (DGE) is a major complication after pancreatic surgery, impacting recovery and hospital stays. The overall DGE grade B/C rate was 11.9%, with 12.7% after pancreatoduodenectomy and 4.2% after left pancreatectomy. No effective treatments for DGE were found, but 12 strategies showed promise in reducing rates, notably minimally invasive left pancreatectomy. Minimally invasive […]

Laparoscopic Resection Rectopexy Outperforms Delorme’s for Rectal Prolapse

Laparoscopic resection rectopexy significantly reduces recurrence rates in full-thickness rectal prolapse compared to Delorme’s procedure. Recurrence rates within 24 months: 8.2% for laparoscopic resection vs. 42.8% for Delorme’s. Laparoscopic surgery had a median time to recurrence of 17.8 months, compared to 8.2 months for Delorme’s. Choose laparoscopic resection for better long-term outcomes and improved quality […]

Neoadjuvant Therapy Improves Outcomes in Intrahepatic Cholangiocarcinoma

Neoadjuvant chemotherapy followed by surgery significantly improves survival and reduces recurrence in patients with potentially resectable intrahepatic cholangiocarcinoma. Median overall survival was 52.9 months for neoadjuvant therapy versus 37.0 months for upfront surgery. Recurrence risk was lower at 57.7% compared to 65.7%, and the time to relapse extended to 16.5 months from 10.7 months. This […]

Gallstone Disease and Lifestyle Factors: A New Approach

Higher lifestyle health scores may reduce gallstone disease risk. A standard deviation increase in Life’s Essential 8 (le8) decreases gallstone odds by 29%. Life’s Crucial 9 (lc9), which includes mental health, reduces odds by 31% and shows better predictive power than le8. Consider integrating lifestyle assessments into patient evaluations to lower gallstone disease risk. lc9 […]